البحث | Bundas24

Aryan Mhatre أضاف وظيفة جديدة أخرى
2025-06-09 06:47:08 -

Amyloidosis Treatment Market Growth Drivers: Share, Value, Size, and Insights
"Executive Summary Amyloidosis Treatment Market Market : The Global Amyloidosis Treatment Market size was valued at USD 5.15 Billion in 2024 and is expected to reach USD 9.60 Billion by 2032, at a CAGR of 8.10 % during the forecast period Value An international Amyloidosis Treatment Market Market research report is an absolute overview of the...

0 التعليقات 0 المشاركات 574 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Ankit Chand أضاف وظيفة جديدة Health
2025-05-13 09:39:43 -

ATTR Amyloidosis Treatment Market is driven by emerging gene therapies
The ATTR Amyloidosis Treatment Market involves pharmaceutical and biotech products designed to treat transthyretin amyloidosis, a rare disorder caused by misfolded transthyretin proteins that deposit as amyloid fibrils in multiple organs. Key therapies include TTR stabilizers, gene-silencing oligonucleotides, and monoclonal antibodies, each offering distinct advantages like improved patient...

0 التعليقات 0 المشاركات 734 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Khushbu Coherent أضاف وظيفة جديدة Health
2025-05-09 07:49:28 -

ATTR Amyloidosis Treatment Market is driven by Innovation
The ATTR Amyloidosis Treatment Market encompasses therapies focused on transthyretin stabilization and gene-silencing approaches to manage cardiomyopathy and polyneuropathy arising from amyloid fibril deposition. Market products include TTR stabilizers such as tafamidis and diflunisal, RNA interference (RNAi) drugs like patisiran, and antisense oligonucleotides exemplified by inotersen. These...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Khushbu Coherent أضاف وظيفة جديدة Health
2025-06-04 10:38:25 -

ATTR Amyloidosis Treatment Market is driven by rising market demand
The ATTR Amyloidosis Treatment Market encompasses therapies designed to address transthyretin (ATTR) amyloidosis, a progressive disorder characterized by abnormal protein deposits in organs and tissues. Core products include RNA interference (RNAi) therapies, monoclonal antibodies, and small-molecule stabilizers that prevent transthyretin misfolding. Advantages of these treatments lie in...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
SPER Market Research أضاف وظيفة جديدة Health
2025-08-18 12:36:44 -

Transthyretin Amyloidosis Treatment Market Trends and Analysis 2034
Transthyretin amyloidosis (ATTR) is a progressive, potentially fatal disorder characterized by the accumulation of misfolded transthyretin proteins in tissues, causing damage mainly to the heart and nerves. Treatment aims to slow or halt the production of these abnormal proteins, manage symptoms, and enhance patients' quality of life. Current options include targeted therapies like tafamidis...

0 التعليقات 0 المشاركات 267 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!